Overview

Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A

Status:
Completed

Trial end date:
2011-04-05

Target enrollment:

Participant gender:

Summary

The study objective is to demonstrate that the UVADEX® Sterile Solution formulation of methoxsalen used in conjunction with the UVAR XTS Photopheresis System can have a clinical effect on the skin manifestations of CTCL (mycosis fungoides) in early stage disease.

Phase:

Phase 4

Details

Lead Sponsor:

M.D. Anderson Cancer Center
Mallinckrodt

Collaborators:

Boston Medical Center
Case Western Reserve University
M.D. Anderson Cancer Center
Mallinckrodt
Rush University Medical Center
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
University of Pittsburgh
Vanderbilt University Medical Center

Treatments:

Methoxsalen